Development of a standard of care for patients with valosin-containing protein associated multisystem proteinopathy

Author:

Korb ManishaORCID,Peck Allison,Alfano Lindsay N.,Berger Kenneth I.,James Meredith K.,Ghoshal Nupur,Healzer Elise,Henchcliffe Claire,Khan Shaida,Mammen Pradeep P. A.,Patel Sujata,Pfeffer Gerald,Ralston Stuart H.,Roy Bhaskar,Seeley William W.,Swenson Andrea,Mozaffar Tahseen,Weihl Conrad,Kimonis Virginia,Fanganiello Roberto,Lee Grace,Mahoney Ryan Patrick,Diaz-Manera Jordi,Evangelista Teresinha,Freimer Miriam,Lloyd Thomas E.,Keung Benison,Kushlaf Hani,Milone Margherita,Needham Merrilee,Palmio Johanna,Stojkovic Tanya,Villar-Quiles Rocío-Nur,Wang Leo H.,Wicklund Matthew P.,Singer Frederick R.,Jones Mallory,Miller Bruce L.,Ahmad Sajjadi S.,Obenaus Andre,Geschwind Michael D.,Al-Chalabi Ammar,Wymer James,Chen Nita,Kompoliti Katie,Wang Stephani C.,Boissoneault Catherine A.,Cruz-Coble Betsaida,Garand Kendrea L.,Rinholen Anna J.,Tabor-Gray Lauren,Rosenfeld Jeffrey,Guo Ming,Peck Nathan,

Abstract

AbstractValosin-containing protein (VCP) associated multisystem proteinopathy (MSP) is a rare inherited disorder that may result in multisystem involvement of varying phenotypes including inclusion body myopathy, Paget’s disease of bone (PDB), frontotemporal dementia (FTD), parkinsonism, and amyotrophic lateral sclerosis (ALS), among others. An international multidisciplinary consortium of 40+ experts in neuromuscular disease, dementia, movement disorders, psychology, cardiology, pulmonology, physical therapy, occupational therapy, speech and language pathology, nutrition, genetics, integrative medicine, and endocrinology were convened by the patient advocacy organization, Cure VCP Disease, in December 2020 to develop a standard of care for this heterogeneous and under-diagnosed disease. To achieve this goal, working groups collaborated to generate expert consensus recommendations in 10 key areas: genetic diagnosis, myopathy, FTD, PDB, ALS, Charcot Marie Tooth disease (CMT), parkinsonism, cardiomyopathy, pulmonology, supportive therapies, nutrition and supplements, and mental health. In April 2021, facilitated discussion of each working group’s conclusions with consensus building techniques enabled final agreement on the proposed standard of care for VCP patients. Timely referral to a specialty neuromuscular center is recommended to aid in efficient diagnosis of VCP MSP via single-gene testing in the case of a known familial VCP variant, or multi-gene panel sequencing in undifferentiated cases. Additionally, regular and ongoing multidisciplinary team follow up is essential for proactive screening and management of secondary complications. The goal of our consortium is to raise awareness of VCP MSP, expedite the time to accurate diagnosis, define gaps and inequities in patient care, initiate appropriate pharmacotherapies and supportive therapies for optimal management, and elevate the recommended best practices guidelines for multidisciplinary care internationally.

Funder

National Institutes of Health

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Genetics (clinical),General Medicine

Reference78 articles.

Cited by 23 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3